Implementation and assessment of vaccination programmes: the importance of vaccination sequence for overall health outcomes

ABSTRACT In addition to their effect on the target infections, accumulating evidence indicates that vaccines have non-specific effects. Live measles vaccine (MV) has beneficial NSEs reducing mortality by more than can be explained by preventing measles infection. In contrast, non-live diphtheria-tetanus-pertussis vaccine (DTP) has negative NSEs; in spite of protecting against diphtheria, tetanus and pertussis, it is associated with increased mortality. The most recent vaccine has the strongest effect on child health, and therefore sequence of vaccines is important. There is consistent evidence that DTP with or after MV is associated with increased mortality compared with having MV as the most recent vaccine, but the sequence of vaccines is not considered in the current evaluation and implementation of vaccination programmes. To maximise the impact of current vaccination programmes on child health, increased emphasis should be placed on receiving MV after DTP. Increasing time with live MV as the most recent vaccine through better adherence to the schedule, and modified recommendations for catch-up vaccinations for children who do not follow the recommended schedule are likely to result in improvements in child health.

[1]  O. Müller,et al.  A Two-Center Randomized Trial of an Additional Early Dose of Measles Vaccine: Effects on Mortality and Measles Antibody Levels , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  J. Mcnicholl,et al.  Risk of Nontargeted Infectious Disease Hospitalizations Among US Children Following Inactivated and Live Vaccines, 2005–2014 , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  F. Binka,et al.  Fewer out-of-sequence vaccinations and reduction of child mortality in Northern Ghana. , 2017, Vaccine.

[4]  H. Whittle,et al.  Does oral polio vaccine have non-specific effects on all-cause mortality? Natural experiments within a randomised controlled trial of early measles vaccine , 2016, BMJ Open.

[5]  J. Sterne,et al.  Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review , 2016, British Medical Journal.

[6]  P. Aaby,et al.  Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections. , 2014, JAMA.

[7]  Peter Aaby,et al.  A small jab - a big effect: nonspecific immunomodulation by vaccines. , 2013, Trends in immunology.

[8]  M. Sodemann,et al.  Vaccination status and sequence of vaccinations as risk factors for hospitalisation among outpatients in a high mortality country. , 2011, Vaccine.

[9]  P. Aaby,et al.  Diphtheria-tetanus-pertussis vaccine administered simultaneously with measles vaccine is associated with increased morbidity and poor growth in girls. A randomised trial from Guinea-Bissau. , 2011, Vaccine.

[10]  Peter Aaby,et al.  Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial , 2010, BMJ : British Medical Journal.

[11]  F. Shann The non-specific effects of vaccines , 2010, Archives of Disease in Childhood.

[12]  Peter Aaby,et al.  Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies , 2003, The Lancet.

[13]  C. Sanderson The actual order in which vaccines are given in the EPI: analysis of data from 102 national surveys. , 2014 .